ArticleGastro hep advances2026
Adenomas and Beyond: Colonoscopy Surveillance, Racial and Socioeconomic Disparities in Lynch Syndrome.
Article in Gastro hep advances, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background and Aims: Pathogenic mutations in the mismatch repair (MMR) genes cause Lynch syndrome. Adenoma resection can prevent colorectal cancer (CRC), but the occurrence of precancerous lesions is understudied in Lynch syndrome. Methods: Using retrospective cohort data, we examined racial and socioeconomic differences in the occurrence of adenoma, sessile serrated lesions (SSLs), and CRC during the first colonoscopy. We also estimated the association between MMR subtype and time to adenoma or SSL occurrence during follow-up colonoscopies. Results: Of the 187 patients included in this study, the most common MMR subtype identified was MSH6 (31.0%). At first colonoscopy, 23% of patients had SSLs, 8.6% had adenomas, and 17.1% of patients had CRC. There was no difference by race or socioeconomic status (SES) in the occurrence of adenoma or SSL at first colonoscopy, but patients of lower SES had greater odds of having CRC (odds ratio: 1.24; 95% confidence interval [CI]: [1.01, 1.52]). During follow-up of patients with normal first colonoscopy, the odds of adenoma or SSL were higher among Conclusion: Adenoma and SSL were highest among
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.